PE-MPs accumulation in liver tissues
PE-MPs were detected in the livers of the experimental groups, whereas no such accumulation was observed in the control group. Nile red staining revealed the presence of PE-MPs in liver tissue sections (Fig 1A). A clear progressive accumulation of PE-MPs with a concentration-dependent pattern was observed across the experimental groups (Fig 1B), consistent with previous findings on MP biodistribution in mammalian organs
(Deng et al., 2017a). Additionally, ATR-FTIR analysis of the liver tissue extracts further confirmed the occurrence of PE-MPs (Fig 1C). The liver sections were examined using the PHAD method showed the occurrence of PE-MPs in the liver tissues of exposed rats. These observations confirmed an increase in hepatic deposition of PE-MPs in a dose-dependent manner (Fig 1D-E), suggesting a proportional relationship between exposure level and bioaccumulation. These results not only confirm hepatic uptake of ingested PE-MPs but also align with earlier studies on tissue retention and distribution of MPs, reinforcing the liver’s role as a primary accumulation and detoxification site.
Histopathological analysis of liver tissues
PE-MPs accumulation in hepatic tissue induced a gradual increase in multifocal centrilobular necrosis and inflammation with increase in dosage of PE-MPs. Compared to the controls, livers from PE-MPs-treated rats also showed notable Leukocyte infiltration and periportal fibrosis (Fig 2A). These histological changes were supported by quantitative morphometric data, which demonstrated significant increases in neutrophil infiltration and fibrotic scores with escalating PE-MP dosages (Fig 2B). This aligns with earlier observations reported by
(Deng et al., 2017a) where fluorescent polystyrene microplastics (PS-MPs) were shown to accumulate in mouse liver and induce oxidative damage and inflammation, laying a foundational understanding of microplastic-induced tissue toxicity. The dose-dependent progression of fibrosis and inflammation observed in our study is consistent with earlier work by
(Lu et al., 2018b) who demonstrated that PS-MP exposure in mice disrupted hepatic lipid metabolism and promoted hepatic steatosis and inflammation. Similarly,
(Zhao et al., 2021) found that chronic PS-MP ingestion triggered immune cell activation and natural killer cell infiltration in the liver, contributing to fibrosis
via immunopathological pathways.
Evaluation of oxidative stress by biochemical assay
Liver tissue extracts from rats were analyzed for ROS levels following PE-MP exposure. No significant changes in ROS levels were detected across any of the exposed doses after 28 days (p>0.05) (Fig 3A), possibly due to the inherently unstable nature of ROS (
Andrés Juan et al., 2021). The PE-MP-exposed groups exhibited significantly higher MDA levels, reflecting enhanced LPO compared to the control group (p<0.05) (Fig 3B). Dose-dependent increase GST activity was showed on PE-MP exposure (p<0.05) (Fig 3C). Furthermore, significant increases in SOD, catalase CAT and total antioxidant capacity were observed in high exposure group (5 mg/kg/day) (Fig 3D-F). At low doses of experiments groups (0.1 mg/kg/day and 1 mg/kg/day), no notable changes were detected in CAT, SOD, or total antioxidant levels (Fig 3D-F). The increase in MDA levels confirms ROS involvement.
Djouina et al. (2023) have shown elevated levels of MDA in mice exposed to PE-MPs, which is further responsible for aggravating liver dysfunction
(Djouina et al., 2023). These data corroborate earlier reports by
Lu et al., (2018c) and
Zhao et al., (2021) who documented similar upregulation of antioxidant defenses in response to polystyrene microplastic (PS-MP) exposure, suggesting a conserved cellular adaptive mechanism across microplastic types.
Transcriptomic analysis, GO and KEGG pathway analysis of DEGs
Fan et al., 2022 reported 293 upregulated and 351 downregulated genes in mice livers after 20 weeks of PS-MPs ingestion.
Wang et al., (2022) observed 69 DEGs gene (low-exposure dose) and 178 (high-exposer dose), with a mix of upregulated and downregulated genes. To explore transcriptional alterations, transcriptome sequencing was performed on liver tissues. A higher dose 5 mg/kg/day PE-MPs were chosen to investigate the molecular mechanisms of liver toxicity following 4 weeks of exposure. The analysis identified 162 differentially expressed genes (DEGs) compared to the control group, comprising 59 down regulated and 103 upregulated genes (|log2FC| > 0), as depicted in the volcano plot (Fig 4A). A heat map of the top 50 DEGs further illustrates the gene expression changes in 5 mg/kg/day group (Fig 4B). Transcriptomic data, validated by five randomly chosen DEGs, selected for quantitative PCR (qPCR) which includes three down regulated genes (CCNB1, CCNA2 and AUNIP) and two upregulated genes (LCN2 and RPL12). The qPCR results corroborated the sequencing findings, supporting the accuracy and reliability of the transcriptomic analysis (Fig 4C-D). KEGG pathway analysis of DEGs showed alterations in lipid metabolism pathways, including prolactin signaling, alcoholic liver disease, PPAR signaling, NAFLD, retinol metabolism and drug metabolism. Gene ontology (GO) annotation further highlighted enrichment in pathways related to cell cycle suppression and negative regulation of apoptosis. Additionally, GO analysis pointed to mitochondrial involvement, with enrichment in oxidative stress-related processes, including mitochondrial transport chains and electron transport functions. These findings suggest that PE-MP exposure disrupts mitochondrial function and lipid metabolism as part of the liver’s adaptive response. Among the top 50 DEGs, several key genes, such as RGD1565355, Hsd17b13, Lpin1, (CD36-like), Car3, Spc25, Xbp1, Pdk4 and Sgms2, were associated with lipid metabolism processing pathways implicated in NAFLD. Analysis of transcriptomic profiles alongside KEGG pathway mapping indicated NAFLD pathway activation in PE-MP-treated liver samples. Given that LPO emerged as a major contributor to liver injury, we further validated its upstream and downstream effects.
Activation of the NAFLD pathway
Exposure to 5 mg/kg/day PE-MPs led to transcriptomic changes affecting lipid metabolic processes and NAFLD-associated pathways, with evident mitochondrial participation. We suggest that mitochondrial impairment drives LPO, leading to inflammatory responses, neutrophil infiltration and fibrosis characteristic of NAFLD. To verify this observation, qPCR analysis showed a significant upregulation of mitochondrial dysfunction-related genes
UQCRH,
NDUFC and MT-CO2 in 5 mg/kg/day group compared to controls (Fig 5A). qPCR validation showed a surge in mRNA levels of
IL-1β,
CXCL1 and
TNF-α key markers of neutrophil infiltration and inflammation involved in NAFLD in the high exposure 5 mg/kg/day PE-MPs group (Fig 5B). Additionally, fibrosis-related genes
(Liu et al., 2021) IL-6,
α-SMA and Col1A1, were also significantly upregulated (Fig 5C). Elevated expression of CXCL1 facilitates the transition from hepatic steatosis to steatohepatitis by increasing oxidative stress and promoting neutrophil infiltration. IL-1
β expression is crucial in the transition from steatosis to NASH and fibrosis, mediated by NLRP3 inflammasome pathway. Experimental data suggest that MPs, including PE-MPs, stimulate pro-inflammatory cytokines expression such as IL-1
β, TNF-
α and CXCL1, thereby aggravating hepatic inflammation and promoting NAFLD
(Musso et al., 2018). These transcriptomic and qPCR findings are consistent with prior studies using other microplastic types such as PS-MPs, which have similarly demonstrated disruption of mitochondrial bioenergetics, inflammation and fibrogenesis in murine models
(Fan et al., 2022; Wang et al., 2022).